0       0

2016 ISHLT Annual Meeting and Scientific Sessions


PMSY01c - PRE-MEETING SYMPOSIUM 01: Anticoagulation and MCS: Can We Do Better? -- Who Should Be Monitoring INR and How?


Apr 27, 2016 8:40am ‐ Apr 27, 2016 8:55am

Description

The goal of this symposium is to familiarize clinicians with current, widely available tests of blood coagulability and pitfalls in their interpretation in the MCS population. Additional topics will include comorbid states, such as acquired von Willebrand’s disease and genetic variations like Factor V mutations, and how they impact patients after device implantation.

Speaker(s):

  • Anna Meyer, MD, Leipzig Heart Center, Leipzig, Germany

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content